THE ROLE OF INTERFERON IN VACCINIA VIRUS INFECTION OF MOUSE EMBRYO TISSUE CULTURE by Glasgow, Lowell A. & Habel, Karl
THE  ROLE  OF  INTERFERON  IN  VACCINIA  VIRUS  INFECTION 
OF  MOUSE  EMBRYO  TISSUE  CULTURE 
BY LOWELL  A.  GLASGOW,  M.D., A~rD KARL HABEL,  M.D. 
(From the Laboratory of Biology of Viruses, National Institute of Allergy and InJectious 
Diseases, National Institutes  of Health, Public Health Service, United States 
Department of Health, Education,  and  Welfare) 
(Received for publication, October 30,  1961) 
Interest in the interference phenomena is currently focused on interferon, a soluble 
product of  influenza virus-infected cells, capable of  interfering with  replication of 
a wide range of viruses (1, 2). Utilizing a number of different cell-virus systems other 
investigators have reported the production of related interferon-like substances with 
the viruses of polio 0,  4)  and  measles  (5)  in human  amuion  cells, myxoviruses in 
MCN  cells (6),  para-influenza 3  virus in  KB  cells  (7),  and  Sindbis virus in  chick 
embryo cells (8). The possible role of interferon in a number of biological phenomena 
has been discussed. Ho and Enders  (4)  demonstrated that the initiation and main- 
tenance  of a  chronic infection with  poliovirus in  human  amnion  cell cultures was 
partially dependent  upon  production  of  interferon.  Henle  (6)  and  coworkers have 
reported  the  production of  an  interferon in  a  myxovirus-MCN carrier culture.  In 
a para-influenza carrier culture Chany (7) postulated that the interferon contributed 
to the establishment of the carrier state, but was less important in maintaining that 
cell-virus relationship.  Baron  and  Isaacs  (9)  have  recently reviewed  the  evidence 
which suggests that interferon may play a  role in the natural recovery process from 
viral infections. In vivo it has been  demonstrated that  in  two  types of viral infec- 
tions-influenza in  mouse  lung  (10)  and  O'ynong-ynong in  mouse  brain  (11),  the 
recovery  process  begins  before  the  appearance  of  antibodies.  In  both  instances, 
demonstrable levels of interferon are present early and may be correlated with  the 
initiation of the recovery process. 
The present study reports an interferon-like substance produced by vaccinia 
virus in mouse  embryo cells in  tissue culture.  The physical properties of this 
substance are defined and its role in the initiation, maintenance, and recovery 
of a  chronic vaccinia infection in vitro is described. 
Materials and Methods 
Virus.--A  calf lymph strain of vaccinia virus maintained by passage in monkey kidney 
cultures was obtained from Dr. Joel Warren. The virus pool was prepared in HeLa cells and 
titered 2  X  10  6 plaque-forming  units  (pfu)  per ml. Sindbis virus was obtained from  Dr. 
Phillip Russell, Walter Reed Army Medical Center, Arbor Virus Unit, as second mouse brain 
passage of an isolate from a Malayan mosquito pool. The Sindbis virus pool was grown in an 
established mouse embryo cell line and titered approximately l0  T  pfu per ml. 
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CdJs.--ME-29 is an established line of mouse embryo cells derived from a C57B1 mouse, 
and is nowin the 75th subculture. Cultures were grown and maintained  in Eagle's medium with 
5-10 per cent calf serum. 
3-B is an established line of mouse embryo cells cloned from a polyoma virus carrier culture. 
The cell  line originated from an NIH random-bred Swiss  mouse and has been grown and 
maintained in Eagle's medium with 5-10 per cent horse serum.  These cells have remained 
polyoma-free for 68 subculture passages since cloning. 
Virus Titration.--Sindbis virus was titered by plaque method in ME-29 cells.  Virus was 
adsorbed for 1~ hours and overlaid with agar medium. A second agar medium overlay con- 
taining 1:30,000  neutral red was made at 24 hours and plaque counts made at 48  and  72 
hours. 
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FIG. 1.  Multiple cycle growth curvesof vaccinia virus in resistant 3-B cells challenged with 
varying input multiplicity compared to a susceptible mouse embryo line (ME-29). 
Vaccinia virus was also quantitated by plaque method in HeLa cells with a 3 hour adsorp- 
tion followed by agar medium overlay. A second overlay with I: 30,000 neutral red was made 
on the 3rd day and counts from the 4th to 6th days. 
Agar medium used for plaque assay contained 0.95 per cent agar in Earle's BSS with 0.I 
per cent bovine albumin and 0.1 per cent yeast extract. 
RESULTS 
During the course of studies of the interference phenomenon a cloned line of 
mouse embryo ceils, 3-B, was observed to be moderately resistant to vaccinia 
virus. The nature of this resistance was investigated. It was noted that the re- 
sistance was partially dependent upon the input multiplicity of the challenge 
virus. Cultures challenged with a multiplicity of 10 to 20 pfu per cell developed 
typical vaccinia cytopathic effect (CPE) within 18 to 24 hours, and by 48 hours 
the  culture  was destroyed.  When  the multiplicity was reduced  to 0.25  to  5, LOWELL  A.  GLASGOW  AND  KARL  HABEL  505 
pock-like areas of CPE appeared after the same interval, but remained circum- 
scribed and did not progress beyond 2-[-, (approximately 25-50 per cent of the 
cell sheet). This resistance could also be demonstrated by the reduced efficiency 
of virus  production in 3-B  cells  challenged  with  a  low  multiplicity  (Fig.  1). 
These data, along with other evidence to be presented, suggested the possibility 
that production of an interfering  substance  by infected  cells  during  the first 
1 to 2 cycles of virus replication reduced the susceptibility of the remaining un- 
infected  cells  in  the  culture.  When fluids  were harvested  from the  vaccinia- 
infected 3-B cultures and were centrifuged to remove the infectious virus parti- 
cles, the supernatant  did in fact contain an inhibitory substance which shares 
many physical characteristics  with previously reported interferons.  Results of 
TABLE I 
Interferon Acti~ty in Fluids  of Resistant 3-B  Cells Infected with  Vaccinia  Virus 
Percentage plaque  Exp. No.  CPE*  Challenge virus  reductions 
1 to 2+ 
2+ 
2+ 
2+ 
Vaccinia 
Vaccinia 
Sindbis 
Sindbis 
p~r g~J 
94 
88 
75 
68 
* At 72 hours in original vaccinia-infected 3-B culture  supplying the interferon. 
:~ Plates were pretreated with 1 cc interferon diluted  1:3 in Eagle's medium for 18 hours. 
Figure represents per cent of the number of plaques in control cultures. 
several experiments in which the interferon activity of the harvests was assayed 
are presented in Table I. 
Production of Interferon.-- 
In the initial  experiments  interferon  preparations  were obtained  by inoculation  of the 
3-B cell line with infective vaccinia virus. 1 liter Blake bottles containing about 5 X  10  e cells 
were infected with approximately  10  e pfu of vaccinia virus.  CPE appeared  at 24 hours  as 
circumscribed pocks which gradually enlarged and increased in number over the next 24 to 36 
hours. By 72 hours further progress was arrested and some regrowth of cells into the areas of 
CPE was observed. At this time fluids were harvested, centrifuged at 2000 m,M for 10 minutes 
to remove cell debris, and then at approximately  50,000 g for 45 minutes. Supernates were 
stored at 4°C and were the source of the interferon. 
At a  later  stage of these  investigations  it was observed that supernates  of 
cultures inoculated with ultraviolet-inactivated  vaccinia demonstrated greater 
interferon  activity  than  did  those  from live virus-infected  cultures.  Vaccinia 
virus was inactivated in a Habel-Sockrider ultraviolet apparatus  (12). 5 ml of 
a  completely  inactivated  virus  preparation  which  had  originally  contained 506  VACCINIA VIRUS  INFECTION 
2.5  X  106 pfu/ml was inoculated into a  1 liter Blake bottle of 3-B cells. Fluids 
were harvested at 40 to 48 hours and interferon preparations made as described 
above. 
Assay of Interferon.- 
Interferon  was assayed by  a  plaque  reduction method.  Monolayers of ME-29  cells  in 
plastic plates were pretreated for 16 to 20 hours with 3 ml of the dilutions of the interferon 
preparation being tested. This was removed and a 0.5 ml challenge inoculum of Sindbis virus 
containing approximately 150 pfu was allowed  to adsorb for 1~ hours. The monolayer was 
then overlaid with agar medium. A second overlay containing neutral red was added at 24 
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FzG. 2.  Titer of interferon activity in harvests of 3-B cultures inoculated with infective 
or ultraviolet-inactivated vaccinia virus. Interferon activity is tested against Sindbis virus by 
plaque reduction method. 
hours and plaque counts were made at 48 and 72 hours. In a number of experiments vaccinia 
was used as the challenge virus. ME-29 cells were pretreated with interferon as described 
above. The inoculum of vaccinia virus containing approximately 150 pfu was removed after 
a 3 hour adsorption period and cultures were incubated in Eagle's medium with 10 per cent 
calf serum. When plaques became visible, usually between 24 and 30 hours after inoculation, 
the fluid  medium was removed and  the cell  monolayers were overlaid with agar  medium 
containing 1 : 50,000 neutral red. Interferon activity was measured as the percentage reduction 
in plaque count in the interferon-treated  plates as compared with control plates treated with a 
similar dilution of spent media harvested from uninfected 3-B cultures. 
Fig. 2 shows the results of a  quantitative assay of the interferon activity in 
harvests  from  cultures  inoculated  with  infective  and  ultraviolet-inactivated 
virus. 
Properties of Vaccinia  Interferon.--The properties of the interfering substance 
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Sedimen~bilicy: The interferon remained in the superuatant following ultracentrifugation 
at 90,000 g for 1 hour. 
Heat Stabgicy: Interferon activity remained aSter heating for 60 minutes at 60°C. Most 
of the activity  was destroyed, however, when preparations were heated at 80°C for 60 minutes. 
pH Stability: The activity of the preparation was not altered by treatment for 18  hours 
at pH 3. 
D/a/ysis: Vaccinia interferon did not diffuse through the membrane when dialyzed for 24 
hours against a balanced salt solution at 4°C. 
Trypsin:  Treatment with 0.1 per cent trypsin at 37°C for 1 hour destroyed 90 per cent of 
the inhibitory activity. 
Ether: Mixture with ether at 4°C for 2 hours destroyed approximately 90 per cent of the 
activity. 
TABLE II 
Sensitivity of Other Viruses to Vo,  c,  cinia Interferon As Determined by Plaque Reduaion Metkod 
in ME-Z9 Cells 
Virus  Interferon  dilution  Percentage plaque reduction 
Vaccinia 
Sindbis 
Encephalomyocarditis 
Herpes simplex 
Eastern equine encephalitis 
Vesicular stomatitis 
1:6 
1:12 
1:6 
1:12 
1:3 
1:3 
1:3 
1:3 
per ¢~ 
100 
95 
100 
80 
98 
94 
90 
53 
Lack  of Association with  Hemagglutinin: The  interferon preparation demonstrated no 
hemagglutinating properties. The soluble hemagglutinin of a normal vaccinia virus pool was 
sedimented by ultracentrifugafion at 50,000 g for 2 hours, whereas a similar sediment of the 
interferon preparation demonstrated no hemagglutinin. 
Antigenic,  iCy: Incubation of the interferon for 2 hours with vaccinia hyperimmune rabbit 
serum caused no loss of activity. 
Viral Specificity.--The  data presented in Table II demonstrate the lack of 
viral specificity of vaccinia interferon. Although all of the viruses tested were 
inhibited, definite differences in sensitivity were  noted.  It is interesting that 
herpes simplex virus which is only moderately sensitive to influenza interferon 
(13) is readily inhibited by vaccinia interferon. In contrast, vesicular stomatitis 
virus which would appear to be relatively sensitive to other interferons (6,  8) 
was the least sensitive of the viruses tested.  Further studies are indicated to 
determine whether such differences: (a) are a  function of the virus-cell system 
used for the assay, (b) depend on a variation in sensitivity among strains of the 
same virus, or (c) reflect actual differences in the activity of viral interferons. 508  VACCINIA  VIRUS  INFECTION 
Cell Specificity.--The vaccinia interferon prepared in mouse embryo cells was 
tested for its ability to inhibit the multiplication of vaccinia virus in heterolo- 
gous cell lines. Activity was assayed by plaque reduction method with vaccinia 
as the challenge virus. Interferon produced in 3-B mouse embryo cells was effec- 
tive in all mouse cell lines studied, but not in primary monkey kidney, chick 
embryo, or rabbit kidney cultures. The exception to this species specificity was 
in the HeLa cell line carried in our laboratory. Our data suggest that the inter- 
feron is partially effective in HeLa cells.  The differences between interferon- 
treated as compared to control HeLa plates were of borderline significance, but 
were consistently present. (Table III). This effect of mouse interferon in a cell 
line of human origin confirms previous evidence (14, 15) that species specificity 
is  not  absolute.  Furthermore,  it  provides  additional  evidence  (16)  of  the 
activity of interferon in some strains of malignant cells. 
TABLE HI 
Effect of Interferon in HeLa Cells 
Exp. No.  Control*  Interferon*  Reduction  p value:[: 
per cent 
1  54.7  31.7  42.5  <0.01 
2  238  171  28  <0.01 
3  62.2  52  16  =0.12 
* Average number of vaccinia plaques per plate in control and interferon-treated groups. 
:~One-tailed t test. 
Interferon Production  and Cell Resistance  in Different  Cell Lines.--The fre- 
quency with which interferon was a product of vaccinia virus infection in other 
cell lines was investigated. Interferon was assayed in the fluids of replicate cul- 
tures of three different mouse cell lines challenged with vaccinia virus. Produc- 
tion of interferon was demonstrated in each of the vaccinia virus-mouse cell 
systems studied; however, quantitative differences were apparent. The results 
given in Table IV suggest an inverse relationship between the susceptibility to 
CPE of mouse cell lines and their capability of producing interferon. 
Vaccinia Carrier  Culture.--As noted before, when the resistant 3-B culture 
was inoculated with a  multiplicity of vaccinia virus varying from 0.25  to 5, 
CPE  was  incomplete.  If  the  culture was  maintained,  virus  replication con- 
tinued, spread of CPE was controlled, and new cell growth could be observed 
in the pock-like areas of cell destruction--a carrier culture. It became apparent, 
however, that the balance of factors necessary to maintain the carrier culture 
was extremely delicate. During the course of our observations all of the theo- 
retically possible outcomes of such  an  equilibrium have been demonstrated: 
(a) imbalance in favor of the infection with rising virus titer and destruction of LOWELL  A.  GLASGOW  AND  KARL  HABEL  509 
the culture,  (b) maintenance of the equilibrium with persistence of the cartier 
state, and (c) imbalance in favor of the factors inhibiting the spread of the virus 
with the culture eventually being cured of its vaccinia infection. 
TABLE IV 
Rdationship  Between Ability  to Produce Interferon and Susceptibility to  CPE by  Vaccinia 
Virus  in  Three Different Mouse Cdl  Cultur~ 
Cell line  Interferon  production*  Susceptibilty:~ 
i~r cent 
Primary mouse embryo ..........  S0  2  X  10  2 pfu 
ME-29 .........................  50  2 X  10  =  pfu 
3-B ............................  95-100  2 X  10  ¢ pfu 
* Per cent plaque reduction of a  150 pfu challenge  of vaccinia virus by the interferon 
preparation produced in the indicated cell line. 
~/No. of pfu of vaccinia virus pool required to produce CPE in the indicated cell line. 
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FIG.  3.  Balance between interferon and virus production in a  vaccinia carrier culture in 
3-B cells. Virus titers are pfu/ml of supematant and interferon quantitation is the per cent 
reduction of 150 pfu of vaccinia by 1 cc of the same samples. 
Studies were  initiated to  quantitate  the role of interferon in this virus-cell 
equilibrium.  Fig.  3  illustrates  an  experiment  in  which  virus  and  interferon 
titers were  determined  over a  5  week period following initiation of vaccinia 
infection in the resistant cell culture. This experiment is an example of an out- 
come in favor of the virus with eventual destruction of the culture and fall of 
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Effect  of  Manipulation  on  Virus-Interferon  Equilibrium.--Attempts  were 
made to alter the equilibrium in the carrier culture. 
Three repficate cultures of 3-B cells were challenged with approximately  0.5 pfu of vaccinia 
virus per cell. Following the initial growth cycles with establishment of the interferon-virus 
balance, one culture was trypsinized every 2nd day, one was subjected to media changes every 
2nd day, while the third was changed at 4 day intervals. Approximately 10-20 per cent of the 
spent medium was allowed to remain in the third culture at the time of the medium change. 
Frequent trypsiniz~tion rapidly shifted the balance in favor of the virus with destruction of 
the culture and rising virus titers. Frequent changes of the medium had the same effect. In 
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FIG. 4.  Enhancement of virus production and CPE by procedures  detrimental to inter- 
feron. Vaccinia virus titers are pfu/ml and interferon quantitation is the per cent reduction of 
150 pfu of vaccinia virus by 1 cc of the sample. 
contrast, the culture that was handled in such a way as to minimize the dilution factor and to 
preserve the interferon was maintained as a carrier culture. 
Fig. 4  confirms the inverse relationship between virus production with CPE 
and interferon production with cell protection. 
Maintenance  of the Carrier  Culture.--The  carrier state which developed fol- 
lowing vaccinia infection of a  3-B culture was moderately unstable. The equi- 
librium between virus and interferon could be maintained by cognizance of the 
effect of handling and media changes. If CPE  appeared to be progressing and 
the virus fiter rose, the culture was changed less frequently and 10-20 per cent 
of the interferon containing spent medium was left in the bottle at the time of 
the change. On the other hand, if CPE seemed to be clearing and the virus titer 
fell, complete media changes were made more frequently. Under such conditions 
vaccinia carrier cultures  could be maintained for  3  to  5  month  periods. The 
cultures which were maintained for this length of time were lost as a  result of 
technical failure and not from imbalance of the virus-interferon equilibrium. LOWELL  A.  GLASGOW  AND  KARL  HABEL  511 
Recovery from Vaccinia Infe~tion.--In several experiments when the carrier 
culture was maintained, under conditions which favored the preservation of the 
interferon,  CPE  gradually  cleared and  the  virus  was  eventually eliminated 
from the culture. This spontaneous recovery was observed to occur from 4 weeks 
to 3 months after the initiation of infection. 
DISCUSSION 
The studies presented demonstrate the production of an interferon-like sub- 
stance in several lines of mouse embryo cells by a  DNA virus, vaccinia. This 
substance is shown to have physical properties similar to  those of influenza 
interferon and other reported interferon-like substances. 
Vaccinia interferon appears to be primarily responsible for the partial resist- 
ance of the cloned line of mouse cells to vaccinia CPE and for the establishment 
and maintenance of a vaccinia carrier culture. 
Considerable evidence has accumulated which suggests that interferon may 
play an important role in the natural recovery from in dvo viral infections. The 
data presented demonstrate the spontaneous recovery of a  cell culture from 
vaccinia virus infection. Evidence suggests that this recovery was mediated by 
interferon. Thus a model for recovery from a virus infection is provided in an 
in dtro system where immunologic mechanisms were not operative. 
Mechanical  manipulation  which  diluted,  or  enzyme treatment  which  de- 
stroyed interferon led to the disruption of the equilibrium between virus and 
interferon in the carrier culture, resulting in a  rising virus titer aud eventual 
complete  CPE.  Such  manipulation  might  prove useful in virus  isolation or 
adaptation procedures where production of interferon could be the factor re- 
sponsible for minimal CPE and low virus titers. 
The data presented add to the evidence suggesting that the production of 
interferon may be a general property of many virus-cell systems. The effect of 
interferon production may be minimal as in the primary mouse and ME-29 
lines, or it may be an important factor in the resistance of a culture as in the 
3-B line. In the susceptible cell lines interferon was produced in low titers, and 
apparently was able to inhibit virus replication only when the inoculum con- 
tained a low multiplicity of vaccinia virus, less than 0.001 pfu/cell. In contrast, 
the resistant 3-B line produced higher titers of interferon when infected with 
vaccinia virus and was resistant to a  100-fold larger virus challenge. Studies in 
progress suggest that this cell line also produces interferon when infected with 
other viruses.  The question arises as  to why this  cell line has  an  enhanced 
ability to respond to virus infection with the production of interferon. It is 
interesting to speculate: (a)  that in the development of the original polyoma 
carrier culture, from which the 3-B line was derived, selection of a  cell more 
efficient in interferon production occurred, or (b) that a step in the process of 
malignant  transformation  induced  by the  polyoma virus  might  involve the 
greater capability for interferon production. 512  VACCINIA VIRUS INFECTION 
SUMMARY 
The production of an interferon-like substance by vaccinia virus is described. 
The physical properties of vaccinia interferon are shown to be similar to those 
of previously reported interferons. 
Data  defining  the role of vaccinia interferon  in cell resistance  and  in estab- 
lishment and maintenance  of a  carrier culture are presented. 
Elimination  of virus from an infected  culture  is demonstrated  and  the  role 
of interferon  in  the  recovery process is considered. 
We should like to thank Dr. David W. Ailing for the statistical analysis of the data, and 
Miss Louise McKerlie  and Mr.  Clarence Corey for their technical help. 
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